RICHMOND, Va., Oct. 20, 2017 -- The Brink’s Company (NYSE:BCO) today announced that it has closed its previously announced 10-year senior unsecured notes offering in an aggregate principal amount of $600 million. The notes were priced at par with an annual interest rate of 4.625% and will mature in October 2027. Brink’s also announced the closing of a $1.5 billion credit facility that includes a $1.0 billion senior secured revolving credit facility and a $500 million senior secured term loan A. Loans under the revolver and term loan mature in 2022 and interest rates float based on a consolidated net leverage grid.
Proceeds from the notes and the credit facility are expected to be used to repay certain existing indebtedness and certain fees and expenses related to the closing of the transactions. Remaining net proceeds are expected to be used for working capital needs, capital expenditures, acquisitions and other general corporate purposes.
About The Brink’s Company
The Brink’s Company (NYSE:BCO) is the world’s premier provider of secure logistics and security solutions including cash-in-transit, ATM services, cash management services (including vault outsourcing, money processing and intelligent safe services), international transportation of valuables, and payment services. Our customers include financial institutions, retailers, government agencies (including central banks), mints, jewelers and other commercial operations. Our global network of operations in 41 countries serve customers in more than 100 countries. For more information, please call 804-289-9709.
Forward-Looking Statements
This release contains forward-looking information. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” and “estimate,” and variations of such words and similar expressions, may identify such forward-looking information. Forward looking information in this release includes, but is not limited to the proposed use of proceeds from the notes offering and credit facility. Forward-looking information in this release is subject to known and unknown risks, uncertainties and contingencies, which are difficult to predict or quantify, and which could cause actual result, performance or achievements to differ materially from those that are anticipated. These and other risks and uncertainties include, but are not limited to, factors discussed under “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2016 and in our other public filings with the Securities and Exchange Commission. The forward-looking information included in this release is representative only as of the date of this document and The Brink’s Company undertakes no obligation to update any information contained in this document.
Contact:
Investor Relations
804.289.9709


Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



